PTK2 and neoplasm: We observed reduced tumor growth in animals that received RA systemically through a slow-release pellet (RA group), and animals where FAK was pharmacologically inhibited (FAKi group); however, in the combined treatment, RA + FAKi induced a more potent inhibition in tumor volume (Figure 5A,B).